Form 990 for tax year 2024
Filed by PEDIATRIC CANCER RESEARCH FOUNDATION.
What the amendment changed
Compared with the return it replaced , filed 2 April 2025. matched by us Only the Part I totals and the names listed in Part VII are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.
- Total revenue
- $1,384,349 changed to $4,224,824
- Total expenses
- $1,912,526 changed to $3,730,243
- Contributions and grants received
- $1,686,095 changed to $4,883,196
- Grants paid
- $914,813 changed to $1,695,918
- Program services expenses
- $1,193,411 changed to $2,261,147
- Management and general expenses
- $80,416 changed to $229,524
- Fundraising expenses
- $638,699 changed to $1,239,572
- Program service expenses (Part III)
- $1,193,411 changed to $2,261,147
Listed only on the earlier return
- JERI WILSON
- THOMAS BRENNAN
Listed only on the later return
- BONNIE LATTIMORE
- JERI WILLSON
- LEN SHULMAN
- MORGAN MARCH
- SAVANNAH SCHMIER
Listed under a different title
- DANIELLE FRAGALLA: CEO (AS OF 03/2024) then CEO
Totals
- Total revenue
- $4,224,824
- Total expenses
- $3,730,243
- Contributions and grants received
- $4,883,196
- Grants paid
- $1,695,918
- Program services expenses (Part IX)
- $2,261,147
- Management and general expenses
- $229,524
- Fundraising expenses
- $1,239,572
- Program service expenses (Part III)
- $2,261,147
Program services were 60.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Listed in Part VII
-
STEVE GIUSTO
PRESIDENT
- Total calculated
- $0
- Hours/week
- 1
-
JOHN COON
VICE PRESIDENT
- Total calculated
- $0
- Hours/week
- 1
-
SCOTT ECKER
TREASURER
- Total calculated
- $0
- Hours/week
- 1
-
BETH ABRAMS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
SUSIE BUCHAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
TIM CROMWELL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
CHERIE DALY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
KEITH KOELLER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
ELIZABETH MCNULTY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JASON O'DONNELL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
AMANDA SARATSIS MD
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JOHN VALLELY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
DARTH VAUGHN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JOHN WEINER
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
NICOLE WILKINS
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
LEN SHULMAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
JERI WILLSON
EXECUTIVE DIRECTOR (THRU 10/2024)
- Total calculated
- $195,263
- From this org
- $188,813
- From related orgs
- $0
- Other
- $6,450
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $188,633
- Bonus
- $0
- Other
- $180
- Deferred
- $6,450
- Nontaxable benefits
- $0
- Filer's total
- $195,263
-
DANIELLE FRAGALLA
CEO
- Total calculated
- $209,723
- From this org
- $202,223
- From related orgs
- $0
- Other
- $7,500
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $201,923
- Bonus
- $0
- Other
- $300
- Deferred
- $7,500
- Nontaxable benefits
- $0
- Filer's total
- $209,723
-
MORGAN MARCH
SENIOR DIRECTOR OF DEVELOPMENT
- Total calculated
- $119,076
- From this org
- $115,704
- From related orgs
- $0
- Other
- $3,372
- Hours/week
- 40
-
BONNIE LATTIMORE
VP OF DEVELOPMENT, STRAT. PTNRSHP
- Total calculated
- $118,400
- From this org
- $115,038
- From related orgs
- $0
- Other
- $3,362
- Hours/week
- 40
-
SAVANNAH SCHMIER
SPECIAL EVENTS MANAGER
- Total calculated
- $108,777
- From this org
- $107,508
- From related orgs
- $0
- Other
- $1,269
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Written employment contract
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$550,000
PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE
-
$204,000
CANCER RESEARCH
-
$150,000
TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS
-
$100,000
TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML
-
$100,000
SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
-
$100,000
TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA
-
$100,000
ADVANCING LIQUID BIOPSIES TO THE CLINIC FOR PATIENTS WITH EWING SARCOMA
-
A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA
-
$37,500
USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS
-
CHILDREN'S HOSPITAL LOS ANGELES
$37,500
PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
PEDIATRIC CANCER RESEARCH FOUNDATION NEW YORK A NOT FOR PROFIT CORPORATION
501(C)(3) · FUNDING SOURCE FOR RESEARCH · NY
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 18 March 2026
- IRS schema version
- 2024v5.5
- Source object
- 202600799349300310
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.